Solventum Corporation vs West Pharmaceutical Services, I
A head-to-head of Solventum Corporation (SOLV) and West Pharmaceutical Services, I (WST) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | SOLV | WST |
|---|---|---|
| Market Cap | $13.57B | $22.35B |
| P/E (TTM) | 9.60 | 42.20 |
| Forward P/E | 10.42 | 34.01 |
| P/S | 1.54 | 6.48 |
| P/B | 2.75 | 7.66 |
| EV/EBITDA | 15.51 | 24.06 |
| Dividend Yield | — | 0.27% |
| Profit Margin | 17.33% | 16.85% |
| Gross Margin | 53.47% | 35.89% |
| Operating Margin | 7.59% | 20.09% |
| Revenue Growth (YoY) | -3.09% | +21.01% |
| FCF Yield | -1.60% | 2.19% |
| Debt / Equity | 102.21 | 7.50 |
| Current Ratio | 1.07 | 2.71 |
Share:
Compare Solventum Corporation with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.